The Nashville Hematology Conference is bringing together top national experts and community practitioners to discuss the latest updates and controversies in the management of hematologic malignancies.
The inaugural conference will be held at the Country Music Hall of Fame® and Museum in Nashville, TN from Thursday February 20, 2025, to Saturday, February 22, 2025, and is purposefully designed to create a fun, informative, and innovative experience that aims to meaningfully engage academic and community practitioners alike.
This two-day CME/CE event is designed to provide attendees with the knowledge needed to confidently navigate the increasingly complex treatment landscapes across hematologic malignancies and manage patients through therapy. Attendees will examine current standards of care and determine how recent data sets may impact their treatment algorithms across various lymphoid and myeloid malignancies. Engaging lectures focused on evolving standards of care, treating relapse after initial therapy, translating T-Cell redirecting therapies into community practice, and treating later relapse will help community practitioners translate new research and innovations within the realm of hematology to practice. Hot topics including health policy, MRD in hematologic malignancies, controversies in treating and much more will also be explored through the community lens.
The Nashville Hematology Conference is bringing together top national experts and community practitioners to discuss the latest updates and controversies in the management of hematologic malignancies. The inaugural conference will be held at the Country Music Hall of Fame® and Museum in Nashville, TN from Thursday February 20, 2025, to Saturday, February 22, 2025, and is purposefully designed to create a fun, informative, and innovative experience that aims to meaningfully engage academic and community practitioners alike.
This two-day CME/CE event is designed to provide attendees with the knowledge needed to confidently navigate the increasingly complex treatment landscapes across hematologic malignancies and manage patients through therapy. Attendees will examine current standards of care and determine how recent data sets may impact their treatment algorithms across various lymphoid and myeloid malignancies.
Engaging lectures focused on evolving standards of care, treating relapse after initial therapy, translating T-Cell redirecting therapies into community practice, and treating later relapse will help community practitioners translate new research and innovations within the realm of hematology to practice. Hot topics including health policy, MRD in hematologic malignancies, controversies in treating and much more will also be explored through the community lens.
Our faculty will examine and debate treatment options across hematologic malignancies keeping the unique challenges community practitioners face at front of mind. Throughout the conference, there will be ample time for live audience questions and opportunities for networking and personal discussions. The Nashville Hematology Conference is meant to provide attendees with the practical tools needed to provide the most current, evidence-based care for patients with hematologic malignancies.
1.Discuss optimal evidence-based management of patients with hematologic malignancies across treatment settings.
2. Share best practices in incorporating T-cell redirecting therapies into practice with particular focus on managing acute and long-term potential toxicities.
3. Apply current prognostic testing to everyday practice across hematologic malignancies and throughout the patient journey.
4. Recognize challenges of treating hematologic malignancies in patients with unmet needs in the community setting including frail patients and disparate populations.
The Omni Nashville will serve as the headquarter hotel for all conference attendees. The hotel is adjacent to the Country Music Hall of Fame® and Museum. Book your room at the Nashville Heme rate today! (Limited availability.)
